Why Is Health Insurance Plan Provider Cigna Stock Trading Higher Today?

Cigna's robust Q4 2023 performance with $51.15 billion in sales, up 12% Y/Y. Dive into the growth of Cigna Healthcare, Evernorth Health Services.

Friday, Cigna Corporation (NYSE:CI) reported fourth-quarter 2023 sales of $ 51.15 billion, up 12% Y/Y, beating the consensus of $48.89 billion, reflecting strong growth across Evernorth Health Services and Cigna Healthcare.

Cigna Healthcare’s fourth quarter adjusted sales increased 17% Y/Y to $13 billion, reflecting customer growth and premium rate increases to cover underlying medical cost trends.

Cigna’s medical cost ratio – or spending on claims as a percentage of premiums – was 82.2% compared to 83.8% a year ago, benefitting from strong performance in the U.S. Healthcare business, including affordability initiatives, effective pricing execution, and favorable stop loss results.

Total premiums during the quarter rose 17% to $11.18 billion. 

Also Read: Cigna’s Medicare Business Sale: Health Care Service Could Scoop The Business.

The total number of medical customers grew 10% from December 31, 2022, to 19.78 million, primarily driven by growth in U.S. Healthcare, including fee-based customers, Individual and Family Plans, and Medicare Advantage customers.

Total pharmacy customers increased 5% to 98.57 million.

Revenue from Cigna’s Evernorth unit, engaged in the pharmacy benefit management business, rose 12% to $40.52 billion, reflecting strong organic growth in specialty pharmacy and care solutions.

The adjusted EPS of $6.79, up from $5.02 a year ago, beat the Wall Street estimate of $6.53.

Cigna declared a cash quarterly dividend of $1.40 per share to be paid on March 21, 2024, to shareholders of record as of the close of trading on March 6, 2024. This reflects a 14% increase from the 2023 cash quarterly dividend of $1.23 per share.

Guidance: Cigna forecasts fiscal year 2024 revenues of at least $235 billion and adjusted EPS of at least $28.25 versus consensus of $229.24 billion and $28.26, respectively.

For fiscal year 2024, the company expects around 19.3 million medical customers.

Cigna sees a fiscal year 2024 medical cost ratio of 81.7%-82.7%.

Price Action: CI shares are up 4.16% at $320.11 during the premarket session on the last check Friday.

Photo via Wikimedia Commons

Total
0
Shares
Related Posts